23 results on '"Magilnick N"'
Search Results
2. MicroRNA-29 negatively regulates expression of oncogene TET2
- Author
-
Li, J., Kramer, N.J., Magilnick, N., and Boldin, M.P.
- Subjects
Gene expression -- Research ,RNA sequencing -- Research ,Genetic research ,MicroRNA -- Physiological aspects ,Science and technology - Abstract
66 MICRORNA-29 NEGATIVELY REGULATES EXPRESSION OF ONCOGENE TET2 MicroRNAs are small, noncoding RNAs that post-transcriptionally regulate gene expression by binding directly to complementary sequences located within the 3' UTRs of [...]
- Published
- 2014
3. Crystal structure of murine aminoacylase 3
- Author
-
Hsieh, J.M., primary, Tsirulnikov, K., additional, Sawaya, M.R., additional, Magilnick, N., additional, Abuladze, N., additional, Kurtz, I., additional, Abramson, J., additional, and Pushkin, A., additional
- Published
- 2010
- Full Text
- View/download PDF
4. Crystal structure of murine aminoacylase 3 in complex with N-acetyl-L-tyrosine
- Author
-
Hsieh, J.M., primary, Tsirulnikov, K., additional, Sawaya, M.R., additional, Magilnick, N., additional, Abuladze, N., additional, Kurtz, I., additional, Abramson, J., additional, and Pushkin, A., additional
- Published
- 2010
- Full Text
- View/download PDF
5. Crystal structure of murine aminoacylase 3 in complex with N-acetyl-S-1,2-dichlorovinyl-L-cysteine
- Author
-
Hsieh, J.M., primary, Tsirulnikov, K., additional, Sawaya, M.R., additional, Magilnick, N., additional, Abuladze, N., additional, Kurtz, I., additional, Abramson, J., additional, and Pushkin, A., additional
- Published
- 2010
- Full Text
- View/download PDF
6. Crystal structure of E177A-mutant murine aminoacylase 3
- Author
-
Hsieh, J.M., primary, Tsirulnikov, K., additional, Sawaya, M.R., additional, Magilnick, N., additional, Abuladze, N., additional, Kurtz, I., additional, Abramson, J., additional, and Pushkin, A., additional
- Published
- 2010
- Full Text
- View/download PDF
7. Structures of aminoacylase 3 in complex with acetylated substrates
- Author
-
Hsieh, J. M., primary, Tsirulnikov, K., additional, Sawaya, M. R., additional, Magilnick, N., additional, Abuladze, N., additional, Kurtz, I., additional, Abramson, J., additional, and Pushkin, A., additional
- Published
- 2010
- Full Text
- View/download PDF
8. Paradoxical attenuation of neuroinflammatory response upon LPS challenge in miR-146b deficient mice.
- Author
-
Chithanathan K, Jürgenson M, Guha M, Yan L, Žarkovskaja T, Pook M, Magilnick N, Boldin MP, Rebane A, Tian L, and Zharkovsky A
- Subjects
- Mice, Animals, Inflammation genetics, Up-Regulation, Cytokines metabolism, Lipopolysaccharides toxicity, MicroRNAs metabolism
- Abstract
The miR-146 family consists of two microRNAs (miRNAs), miR-146a and miR-146b (miR-146a/b), both of which are known to suppress immune responses in a variety of conditions. Here, we studied how constitutive deficiency of miR-146b ( Mir146b-/- ) affects lipopolysaccharide (LPS)-induced neuroinflammation in mice. Our experiments demonstrated that miR-146b deficiency results in the attenuation of LPS-induced neuroinflammation, as it was evidenced by the reduction of sickness behavior, a decrease in the inflammatory status of microglia, and the loss of morphological signs of microglial activation in the hippocampus. Gene expression analysis revealed that LPS-induced upregulation of hippocampal pro-inflammatory cytokines is attenuated in Mir146b-/- mice, compared to wild-type ( WT ) mice. In addition, reduced expression of the NF-κB nuclear protein p65, reduced miR-146 family target TLR4 expression and relatively stronger upregulation of miR- 146a was found in Mir146b-/- mice as compared to WT mice upon LPS challenge. Compensatory upregulation of miR-146a can explain the attenuation of the LPS-induced neuroinflammation. This was supported by experiments conducted with miR-146a/b deficient mice ( Mir146a/b-/- ), which demonstrated that additional deletion of the miR-146a led to the restoration of LPS-induced sickness behavior and proinflammatory cytokines. Our experiments also showed that the observed upregulation of miR-146a in Mir146b-/- mice is due to the overexpression of a miR-146a transcription inducer, interferon regulatory factor 7 ( Irf7 ). Altogether, our results show the existence of crosstalk between miR-146a and mir-146b in the regulation of LPS-induced neuroinflammation., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Chithanathan, Jürgenson, Guha, Yan, Žarkovskaja, Pook, Magilnick, Boldin, Rebane, Tian and Zharkovsky.)
- Published
- 2022
- Full Text
- View/download PDF
9. Enhanced Cognition and Neurogenesis in miR-146b Deficient Mice.
- Author
-
Chithanathan K, Somelar K, Jürgenson M, Žarkovskaja T, Periyasamy K, Yan L, Magilnick N, Boldin MP, Rebane A, Tian L, and Zharkovsky A
- Subjects
- Animals, Cognition, Mice, Neurogenesis, RNA, Messenger, Glial Cell Line-Derived Neurotrophic Factor, MicroRNAs genetics, MicroRNAs metabolism
- Abstract
The miR-146 family consists of two microRNAs (miRNAs), miR-146a and miR-146b, which are both known to suppress a variety of immune responses. Here in this study, we show that miR-146b is abundantly expressed in neuronal cells, while miR-146a is mainly expressed in microglia and astroglia of adult mice. Accordingly, miR-146b deficient ( Mir146b -/-) mice exhibited anxiety-like behaviors and enhanced cognition. Characterization of cellular composition of Mir146b -/- mice using flow cytometry revealed an increased number of neurons and a decreased abundancy of astroglia in the hippocampus and frontal cortex, whereas microglia abundancy remained unchanged. Immunohistochemistry showed a higher density of neurons in the frontal cortex of Mir146b -/- mice, enhanced hippocampal neurogenesis as evidenced by an increased proliferation, and survival of newly generated cells with enhanced maturation into neuronal phenotype. No microglial activation or signs of neuroinflammation were observed in Mir146b -/- mice. Further analysis demonstrated that miR-146b deficiency is associated with elevated expression of glial cell line-derived neurotrophic factor ( Gdnf ) mRNA in the hippocampus, which might be at least in part responsible for the observed neuronal expansion and the behavioral phenotype. This hypothesis is partially supported by the positive correlation between performance of mice in the object recognition test and Gdnf mRNA expression in Mir146b -/- mice. Together, these results show the distinct function of miR-146b in controlling behaviors and provide new insights in understanding cell-specific function of miR-146b in the neuronal and astroglial organization of the mouse brain.
- Published
- 2022
- Full Text
- View/download PDF
10. Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbation.
- Author
-
Laanesoo A, Urgard E, Periyasamy K, Laan M, Bochkov YA, Aab A, Magilnick N, Pooga M, Gern JE, Johnston SL, Coquet JM, Boldin MP, Wengel J, Altraja A, Bochenek G, Jakiela B, and Rebane A
- Subjects
- Adult, Allergens, Animals, Asthma etiology, Asthma metabolism, Disease Models, Animal, Female, Humans, Hypersensitivity etiology, Hypersensitivity metabolism, Inflammation etiology, Inflammation metabolism, Male, Mice, Picornaviridae Infections virology, Rhinovirus physiology, Asthma pathology, Hypersensitivity pathology, Inflammation pathology, MicroRNAs genetics, Picornaviridae Infections complications, Th2 Cells immunology
- Abstract
Rhinovirus (RV) infections are associated with asthma exacerbations. MicroRNA-146a and microRNA-146b (miR-146a/b) are anti-inflammatory miRNAs that suppress signaling through the nuclear factor kappa B (NF-κB) pathway and inhibit pro-inflammatory chemokine production in primary human bronchial epithelial cells (HBECs). In the current study, we aimed to explore whether miR-146a/b could regulate cellular responses to RVs in HBECs and airways during RV-induced asthma exacerbation. We demonstrated that expression of miR-146a/b and pro-inflammatory chemokines was increased in HBECs and mouse airways during RV infection. However, transfection with cell-penetrating peptide (CPP)-miR-146a nanocomplexes before infection with RV significantly reduced the expression of the pro-inflammatory chemokines CCL5, IL-8 and CXCL1, increased interferon-λ production, and attenuated infection with the green fluorescent protein (GFP)-expressing RV-A16 in HBECs. Concordantly, compared to wild-type (wt) mice, Mir146a/b
-/- mice exhibited more severe airway neutrophilia and increased T helper (Th)1 and Th17 cell infiltration in response to RV-A1b infection and a stronger Th17 response with a less prominent Th2 response in house dust mite extract (HDM)-induced allergic airway inflammation and RV-induced exacerbation models. Interestingly, intranasal administration of CPP-miR-146a nanocomplexes reduced HDM-induced allergic airway inflammation without a significant effect on the Th2/Th1/Th17 balance in wild-type mice. In conclusion, the overexpression of miR-146a has a strong anti-inflammatory effect on RV infection in HBECs and a mouse model of allergic airway inflammation, while a lack of miR-146a/b leads to attenuated type 2 cell responses in mouse models of allergic airway inflammation and RV-induced exacerbation of allergic airway inflammation. Furthermore, our data indicate that the application of CPP-miR-146a nanocomplexes has therapeutic potential for targeting airway inflammation., (© 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.)- Published
- 2021
- Full Text
- View/download PDF
11. microRNA-146a controls age-related bone loss.
- Author
-
Saferding V, Hofmann M, Brunner JS, Niederreiter B, Timmen M, Magilnick N, Hayer S, Heller G, Steiner G, Stange R, Boldin M, Schabbauer G, Weigl M, Hackl M, Grillari J, Smolen JS, and Blüml S
- Subjects
- Animals, Bone Resorption genetics, Bone Resorption pathology, Cell Differentiation physiology, Epigenesis, Genetic, Female, Male, Mice, MicroRNAs metabolism, Osteoblasts cytology, Osteoporosis pathology, Wnt-5a Protein metabolism, Wnt1 Protein metabolism, MicroRNAs genetics, Osteoporosis genetics
- Abstract
Bone loss is one of the consequences of aging, leading to diseases such as osteoporosis and increased susceptibility to fragility fractures and therefore considerable morbidity and mortality in humans. Here, we identify microRNA-146a (miR-146a) as an essential epigenetic switch controlling bone loss with age. Mice deficient in miR-146a show regular development of their skeleton. However, while WT mice start to lose bone with age, animals deficient in miR-146a continue to accrue bone throughout their life span. Increased bone mass is due to increased generation and activity of osteoblasts in miR-146a-deficient mice as a result of sustained activation of bone anabolic Wnt signaling during aging. Deregulation of the miR-146a target genes Wnt1 and Wnt5a parallels bone accrual and osteoblast generation, which is accompanied by reduced development of bone marrow adiposity. Furthermore, miR-146a-deficient mice are protected from ovariectomy-induced bone loss. In humans, the levels of miR-146a are increased in patients suffering fragility fractures in comparison with those who do not. These data identify miR-146a as a crucial epigenetic temporal regulator which essentially controls bone homeostasis during aging by regulating bone anabolic Wnt signaling. Therefore, miR-146a might be a powerful therapeutic target to prevent age-related bone dysfunctions such as the development of bone marrow adiposity and osteoporosis., (© 2020 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
12. Molecular Moirai: Long Noncoding RNA Mediators of HSC Fate.
- Author
-
Magilnick N and Boldin MP
- Abstract
Purpose of Review: Hematopoiesis is an ordered developmental process that requires dynamic regulation to warrant proper response to physiological challenges and prevent malignancies. Long noncoding RNAs are emerging as key, multi-faceted regulators of gene expression. This review explores the function of lncRNAs in the control of HSC homeostasis and hematopoietic differentiation., Recent Findings: Multiple lncRNAs have been implicated in maintaining HSC stemness and enabling progenitors to carry out the correct programs of lineage differentiation. Specific lncRNAs have been identified that regulate the differentiation of multipotent progenitors into terminally differentiated blood cells. These lncRNAs predominantly act by assisting master regulators that drive specific differentiation programs, either by enhancing or repressing the transcription of particular genomic loci., Summary: Long noncoding RNAs contribute to the correct differentiation and maturation of various hematopoietic lineages by assisting with the activation of transcriptional programs in a time- and cell-dependent manner., Competing Interests: Compliance with Ethical Standards Conflict of Interest Nathaniel Magilnick and Mark P. Boldin declare that they have no conflict of interest.
- Published
- 2018
- Full Text
- View/download PDF
13. miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis.
- Author
-
Hermann H, Runnel T, Aab A, Baurecht H, Rodriguez E, Magilnick N, Urgard E, Šahmatova L, Prans E, Maslovskaja J, Abram K, Karelson M, Kaldvee B, Reemann P, Haljasorg U, Rückert B, Wawrzyniak P, Weichenthal M, Mrowietz U, Franke A, Gieger C, Barker J, Trembath R, Tsoi LC, Elder JT, Tkaczyk ER, Kisand K, Peterson P, Kingo K, Boldin M, Weidinger S, Akdis CA, and Rebane A
- Subjects
- Animals, Apoptosis genetics, Case-Control Studies, Cells, Cultured, Dermatitis genetics, Dermatitis pathology, Disease Models, Animal, Humans, Mice, Mice, Inbred C57BL, Psoriasis pathology, Real-Time Polymerase Chain Reaction methods, Cell Proliferation genetics, Gene Expression Regulation, Keratinocytes metabolism, MicroRNAs genetics, Psoriasis genetics
- Abstract
miR-146a inhibits inflammatory responses in human keratinocytes and in different mouse models of skin inflammation. Little is known about the role of miR-146b in the skin. In this study, we confirmed the increased expression of miR-146a and miR-146b (miR-146a/b) in the lesional skin of patients with psoriasis. The expression of miR-146a was approximately twofold higher than that of miR-146b in healthy human skin, and it was more strongly induced by stimulation of proinflammatory cytokines in keratinocytes and fibroblasts. miR-146a/b target genes regulating inflammatory responses or proliferation were altered in the skin of patients with psoriasis, among which FERMT1 was verified as a direct target of miR-146a. In silico analysis of genome-wide data from >4,000 psoriasis cases and >8,000 controls confirmed a moderate association between psoriasis and genetic variants in the miR-146a encoding gene. Transfection of miR-146a/b suppressed and inhibition enhanced keratinocyte proliferation and the expression of psoriasis-related target genes. Enhanced expression of miR-146a/b-influenced genes was detected in cultured keratinocytes from miR-146a
-/- and skin fibroblasts from miR-146a-/- and miR-146b-/- mice stimulated with psoriasis-associated cytokines as compared with wild-type mice. Our results indicate that besides miR-146a, miR-146b is expressed and might be capable of modulation of inflammatory responses and keratinocyte proliferation in psoriatic skin., (Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
14. miR-146a - Traf6 regulatory axis controls autoimmunity and myelopoiesis, but is dispensable for hematopoietic stem cell homeostasis and tumor suppression.
- Author
-
Magilnick N, Reyes EY, Wang WL, Vonderfecht SL, Gohda J, Inoue JI, and Boldin MP
- Subjects
- Animals, Female, Gene Expression Regulation, Hematopoietic Stem Cells immunology, Homeostasis, Humans, Inflammation genetics, Inflammation physiopathology, Male, Mice, MicroRNAs genetics, Myeloid Cells cytology, Myeloid Cells immunology, Neoplasms genetics, Neoplasms physiopathology, TNF Receptor-Associated Factor 6 genetics, Autoimmunity, Hematopoietic Stem Cells cytology, Inflammation immunology, MicroRNAs immunology, Myelopoiesis, Neoplasms immunology, TNF Receptor-Associated Factor 6 immunology
- Abstract
microRNA-146a ( miR-146a ) has been previously implicated as an essential molecular brake, preventing immune overreaction and malignant transformation by attenuating NF-κB signaling, putatively via repression of the Traf6 and Irak1 genes. The exact contribution of miR-146a -mediated silencing of these genes to the control of immune activation is currently unknown. Therefore, we defined the role of the miR-146a - Traf6 signaling axis in the regulation of immune homeostasis using a genetic epistasis analysis in miR-146a
-/- mice. We have uncovered a surprising separation of functions at the level of miR-146a targets. Lowering the Traf6 gene dose and consequent attenuation of NF-κB activation rescued several significant miR-146a-/- phenotypes, such as splenomegaly, aberrant myeloproliferation, and excessive inflammatory responses. In contrast, decreasing Traf6 expression had no effect on the development of the progressive bone marrow failure phenotype, as well as lymphomagenesis in miR-146a-/- mice, indicating that miR-146a controls these biological processes through different molecular mechanisms., Competing Interests: The authors declare no conflict of interest.- Published
- 2017
- Full Text
- View/download PDF
15. Atherosclerosis-Driven Treg Plasticity Results in Formation of a Dysfunctional Subset of Plastic IFNγ+ Th1/Tregs.
- Author
-
Butcher MJ, Filipowicz AR, Waseem TC, McGary CM, Crow KJ, Magilnick N, Boldin M, Lundberg PS, and Galkina EV
- Subjects
- Animals, Atherosclerosis immunology, Interferon-gamma immunology, Mice, Mice, Inbred C57BL, Mice, Knockout, T-Lymphocyte Subsets immunology, T-Lymphocyte Subsets metabolism, T-Lymphocytes, Regulatory immunology, Th1 Cells immunology, Atherosclerosis metabolism, Cell Plasticity physiology, Interferon-gamma metabolism, T-Lymphocytes, Regulatory metabolism, Th1 Cells metabolism
- Abstract
Rationale: Forkhead box P3
+ T regulatory cells (Tregs) are key players in maintaining immune homeostasis. Evidence suggests that Tregs respond to environmental cues to permit or suppress inflammation. In atherosclerosis, Th1-driven inflammation affects Treg homeostasis, but the mechanisms governing this phenomenon are unclear., Objective: Here, we address whether atherosclerosis impacts Treg plasticity and functionality in Apoe- /- mice, and what effect Treg plasticity might have on the pathology of atherosclerosis., Methods and Results: We demonstrate that atherosclerosis promotes Treg plasticity, resulting in the reduction of CXCR3+ Tregs and the accumulation of an intermediate Th1-like interferon (IFN)-γ+ CCR5+ Treg subset (Th1/Tregs) within the aorta. Importantly, Th1/Tregs arise in atherosclerosis from bona fide Tregs, rather than from T-effector cells. We show that Th1/Tregs recovered from atherosclerotic mice are dysfunctional in suppression assays. Using an adoptive transfer system and plasticity-prone Mir146a-/- Tregs, we demonstrate that elevated IFNγ+ Mir146a-/- Th1/Tregs are unable to adequately reduce atherosclerosis, arterial Th1, or macrophage content within Apoe-/- mice, in comparison to Mir146a+/+ Tregs. Finally, via single-cell RNA-sequencing and real-time -polymerase chain reaction, we show that Th1/Tregs possess a unique transcriptional phenotype characterized by coexpression of Treg and Th1 lineage genes and a downregulation of Treg-related genes, including Ikzf2, Ikzf4, Tigit, Lilrb4, and Il10. In addition, an ingenuity pathway analysis further implicates IFNγ, IFNα, interleukin-2, interleukin-7, CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), T-cell receptor, and Csnk2b-related pathways in regulating Treg plasticity., Conclusions: Atherosclerosis drives Treg plasticity, resulting in the accumulation of dysfunctional IFNγ+ Th1/Tregs that may permit further arterial inflammation and atherogenesis., (© 2016 American Heart Association, Inc.)- Published
- 2016
- Full Text
- View/download PDF
16. Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy.
- Author
-
Bhatt K, Lanting LL, Jia Y, Yadav S, Reddy MA, Magilnick N, Boldin M, and Natarajan R
- Subjects
- Animals, Inflammation etiology, Macrophages, Mice, Diabetic Nephropathies etiology, MicroRNAs physiology
- Abstract
Inflammation has a critical role in the pathogenesis of diabetic complications, including diabetic nephropathy (DN). MicroRNAs have recently emerged as important regulators of DN. However, the role of microRNAs in the regulation of inflammation during DN is poorly understood. Here, we examined the in vivo role of microRNA-146a (miR-146a), a known anti-inflammatory microRNA, in the pathogenesis of DN. In a model of streptozotocin-induced diabetes, miR-146a(-/-) mice showed significantly exacerbated proteinuria, renal macrophage infiltration, glomerular hypertrophy, and fibrosis relative to the respective levels in control wild-type mice. Diabetes-induced upregulation of proinflammatory and profibrotic genes was significantly greater in the kidneys of miR-146a(-/-) than in the kidneys of wild-type mice. Notably, miR-146a expression increased in both peritoneal and intrarenal macrophages in diabetic wild-type mice. Mechanistically, miR-146a deficiency during diabetes led to increased expression of M1 activation markers and suppression of M2 markers in macrophages. Concomitant with increased expression of proinflammatory cytokines, such as IL-1β and IL-18, markers of inflammasome activation also increased in the macrophages of diabetic miR-146a(-/-) mice. These studies suggest that in early DN, miR-146a upregulation exerts a protective effect by downregulating target inflammation-related genes, resulting in suppression of proinflammatory and inflammasome gene activation. Loss of this protective mechanism in miR-146a(-/-) mice leads to accelerated DN. Taken together, these results identify miR-146a as a novel anti-inflammatory noncoding RNA modulator of DN., (Copyright © 2016 by the American Society of Nephrology.)
- Published
- 2016
- Full Text
- View/download PDF
17. Single particle electron microscopy analysis of the bovine anion exchanger 1 reveals a flexible linker connecting the cytoplasmic and membrane domains.
- Author
-
Jiang J, Magilnick N, Tsirulnikov K, Abuladze N, Atanasov I, Ge P, Narla M, Pushkin A, Zhou ZH, and Kurtz I
- Subjects
- Animals, Cattle, Cytoplasm ultrastructure, Electrophoresis, Polyacrylamide Gel, Immunoblotting, Protein Structure, Tertiary, Anion Exchange Protein 1, Erythrocyte metabolism, Anion Exchange Protein 1, Erythrocyte ultrastructure, Microscopy, Electron methods
- Abstract
Anion exchanger 1 (AE1) is the major erythrocyte membrane protein that mediates chloride/bicarbonate exchange across the erythrocyte membrane facilitating CO₂ transport by the blood, and anchors the plasma membrane to the spectrin-based cytoskeleton. This multi-protein cytoskeletal complex plays an important role in erythrocyte elasticity and membrane stability. An in-frame AE1 deletion of nine amino acids in the cytoplasmic domain in a proximity to the membrane domain results in a marked increase in membrane rigidity and ovalocytic red cells in the disease Southeast Asian Ovalocytosis (SAO). We hypothesized that AE1 has a flexible region connecting the cytoplasmic and membrane domains, which is partially deleted in SAO, thus causing the loss of erythrocyte elasticity. To explore this hypothesis, we developed a new non-denaturing method of AE1 purification from bovine erythrocyte membranes. A three-dimensional (3D) structure of bovine AE1 at 2.4 nm resolution was obtained by negative staining electron microscopy, orthogonal tilt reconstruction and single particle analysis. The cytoplasmic and membrane domains are connected by two parallel linkers. Image classification demonstrated substantial flexibility in the linker region. We propose a mechanism whereby flexibility of the linker region plays a critical role in regulating red cell elasticity.
- Published
- 2013
- Full Text
- View/download PDF
18. Mouse aminoacylase 3: a metalloenzyme activated by cobalt and nickel.
- Author
-
Tsirulnikov K, Abuladze N, Newman D, Ryazantsev S, Wolak T, Magilnick N, Koag MC, Kurtz I, and Pushkin A
- Subjects
- Amidohydrolases chemistry, Amidohydrolases genetics, Amidohydrolases isolation & purification, Animals, Cloning, Molecular, Enzyme Activation, HeLa Cells, Humans, Mice, Models, Molecular, Protein Conformation, Amidohydrolases metabolism, Cobalt pharmacology, Nickel pharmacology
- Abstract
Aminoacylase 3 (AA3) deacetylates N-acetyl-aromatic amino acids and mercapturic acids including N-acetyl-1,2-dichlorovinyl-L-cysteine (Ac-DCVC), a metabolite of a xenobiotic trichloroethylene. Previous studies did not demonstrate metal-dependence of AA3 despite a high homology with a Zn(2+)-metalloenzyme aminoacylase 2 (AA2). A 3D model of mouse AA3 was created based on homology with AA2. The model showed a putative metal binding site formed by His21, Glu24 and His116, and Arg63, Asp68, Asn70, Arg71, Glu177 and Tyr287 potentially involved in catalysis/substrate binding. The mutation of each of these residues to alanine inactivated AA3 except Asn70 and Arg71, therefore the corrected 3D model of mouse AA3 was created. Wild type (wt) mouse AA3 expressed in E. coli contained approximately 0.35 zinc atoms per monomer. Incubation with Co(2+) and Ni(2+) activated wt-AA3. In the cobalt-activated AA3 zinc was replaced with cobalt. Metal removal completely inactivated wt-AA3, whereas addition of Zn(2+), Mn(2+) or Fe(2+) restored initial activity. Co(2+) and to a lesser extent Ni(2+) increased activity several times in comparison with intact wt-AA3. Co(2+) drastically increased the rate of deacetylation of Ac-DCVC and significantly increased the toxicity of Ac-DCVC in the HEK293T cells expressing wt-AA3. The results indicate that AA3 is a metalloenzyme significantly activated by Co(2+) and Ni(2+).
- Published
- 2009
- Full Text
- View/download PDF
19. Effects of hepatocyte growth factor on glutathione synthesis, growth, and apoptosis is cell density-dependent.
- Author
-
Yang H, Magilnick N, Xia M, and Lu SC
- Subjects
- Animals, Cell Count, Cells, Cultured, Glutamate-Cysteine Ligase genetics, Glutamate-Cysteine Ligase metabolism, Glutathione Synthase genetics, Glutathione Synthase metabolism, JNK Mitogen-Activated Protein Kinases metabolism, Promoter Regions, Genetic, Rats, Signal Transduction, Tumor Necrosis Factor-alpha metabolism, Apoptosis, Glutathione biosynthesis, Hepatocyte Growth Factor pharmacology
- Abstract
Hepatocyte growth factor (HGF) is a potent hepatocyte mitogen that exerts opposing effects depending on cell density. Glutathione (GSH) is the main non-protein thiol in mammalian cells that modulates growth and apoptosis. We previously showed that GSH level is inversely related to cell density of hepatocytes and is positively related to growth. Our current work examined whether HGF can modulate GSH synthesis in a cell density-dependent manner and how GSH in turn influence HGF's effects. We found HGF treatment of H4IIE cells increased cell GSH levels only under subconfluent density. The increase in cell GSH under low density was due to increased transcription of GSH synthetic enzymes. This correlated with increased protein levels and nuclear binding activities of c-Jun, c-Fos, p65, p50, Nrf1 and Nrf2 to the promoter region of these genes. HGF acts as a mitogen in H4IIE cells under low cell density and protects against tumor necrosis factor alpha (TNFalpha)-induced apoptosis by limiting JNK activation. However, HGF is pro-apoptotic under high cell density and exacerbates TNFalpha-induced apoptosis by potentiating JNK activation. The increase in cell GSH under low cell density allows HGF to exert its full mitogenic effect but is not necessary for its anti-apoptotic effect.
- Published
- 2008
- Full Text
- View/download PDF
20. Expression pattern, regulation, and functions of methionine adenosyltransferase 2beta splicing variants in hepatoma cells.
- Author
-
Yang H, Ara AI, Magilnick N, Xia M, Ramani K, Chen H, Lee TD, Mato JM, and Lu SC
- Subjects
- Apoptosis physiology, Case-Control Studies, Cell Culture Techniques, Cell Line, Gene Expression Profiling, Humans, RNA Splicing genetics, Tumor Necrosis Factor-alpha physiology, Carcinoma, Hepatocellular genetics, Carcinoma, Hepatocellular metabolism, Gene Expression Regulation, Neoplastic physiology, Liver Neoplasms genetics, Liver Neoplasms metabolism, Methionine Adenosyltransferase physiology
- Abstract
Background & Aims: Methionine adenosyltransferase (MAT) catalyzes S-adenosylmethionine biosynthesis. Two genes (MAT1A and MAT2A) encode for the catalytic subunit of MAT, while a third gene (MAT2beta) encodes for a regulatory subunit that modulates the activity of MAT2A-encoded isoenzyme. We uncovered multiple splicing variants while characterizing its 5'-flanking region. The aims of our current study are to examine the expression pattern, regulation, and functions of the 2 major variants: V1 and V2., Methods: Studies were conducted using RNA from normal human tissues, resected hepatocellular carcinoma specimens, and cell lines. Gene expression, promoter and nuclear binding activities, growth, and apoptosis were measured by routine assays., Results: MAT2beta is expressed in most but not all tissues, and the 2 variants are differentially expressed. The messenger RNA levels of both variants are markedly increased in hepatocellular carcinoma. Tumor necrosis factor (TNF)-alpha, which induces MAT2A in HepG2 cells, also induced V1 (but not V2) expression. TNF-alpha induced the promoter activity of MAT2beta V1, likely via nuclear factor kappaB and activator protein 1. Both variants regulate growth, but only V1 regulates apoptosis. Reduced expression of V1 led to c-Jun-N-terminal kinase (JNK) activation, apoptosis, and sensitized HepG2 cells to TNF-alpha-induced apoptosis, while overexpression of V1 was protective. However, blocking JNK1 or JNK2 activation did not prevent apoptosis induced by V1 knockdown. V1 (but not V2) knockdown also leads to apoptosis in a colon cancer cell line, suggesting these variants play similar roles in many cell types., Conclusions: Different variants of MAT2beta regulate growth and death, which broadens their importance in biology.
- Published
- 2008
- Full Text
- View/download PDF
21. Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells.
- Author
-
Yang H, Magilnick N, Noureddin M, Mato JM, and Lu SC
- Subjects
- Carcinoma, Hepatocellular metabolism, Cell Count, Cell Line, Tumor, Cyclin A genetics, Cyclin A metabolism, Cyclin-Dependent Kinase Inhibitor p21 genetics, Cyclin-Dependent Kinase Inhibitor p21 metabolism, Extracellular Signal-Regulated MAP Kinases physiology, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Humans, Liver Neoplasms metabolism, Methionine Adenosyltransferase metabolism, Proliferating Cell Nuclear Antigen genetics, Proliferating Cell Nuclear Antigen metabolism, Proto-Oncogene Proteins c-met genetics, Proto-Oncogene Proteins c-met metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Signal Transduction physiology, Carcinoma, Hepatocellular genetics, Carcinoma, Hepatocellular pathology, Cell Proliferation, Hepatocyte Growth Factor physiology, Liver Neoplasms genetics, Liver Neoplasms pathology, Methionine Adenosyltransferase genetics
- Abstract
Hepatocyte growth factor (HGF) is a potent hepatocyte mitogen but its effect in liver cancer is conflicting. Methionine adenosyltransferase (MAT) is an essential enzyme encoded by two genes (MAT1A and MAT2A), while a third gene (MAT2beta) encodes for a subunit that regulates the MAT2A-encoded isoenzyme. MAT1A is silenced while MAT2A and MAT2beta are induced in hepatocellular carcinoma (HCC). The current work examined expression of HGF/c-met in HCC and whether HGF regulates MAT genes and growth in HepG2 cells. We found the mRNA levels of HGF and c-met are markedly increased in HCC. To study the influence of cell density, HepG2 cells were plated under high-density (HD) or low-density (LD) and treated with HGF (10 ng/ml). Cell density had a dramatic effect on MAT1A expression, being nearly undetectable at LD to a ninefold induction under HD. Cell density also determined the effect of HGF. At HD, HGF increased the mRNA levels of p21 and p27, while lowering the levels of MAT genes, cyclin A, and c-met. At LD, HGF increased the mRNA levels of cyclin A, MAT2A, MAT2beta, and c-met. Consistently, HGF inhibits growth under HD but stimulates growth under LD. HGF induced sustained high ERK activation under HD as compared to LD. In summary, HGF induces genes favoring growth and is mitogenic when HepG2 cells are plated under LD; however, the opposite occurs under HD. This involves cell density-dependent differences in HGF-induced ERK activation. This may explain why HGF is mitogenic only when there is loss of cell-cell contact in vivo., (Copyright 2006 Wiley-Liss, Inc.)
- Published
- 2007
- Full Text
- View/download PDF
22. Tumour necrosis factor alpha induces co-ordinated activation of rat GSH synthetic enzymes via nuclear factor kappaB and activator protein-1.
- Author
-
Yang H, Magilnick N, Ou X, and Lu SC
- Subjects
- 5' Flanking Region genetics, Animals, Base Sequence, Cell Line, Tumor, Gene Deletion, Glutamate-Cysteine Ligase genetics, Glutathione Synthase genetics, Humans, Molecular Sequence Data, NF-E2-Related Factor 2 metabolism, NF-kappa B genetics, Promoter Regions, Genetic genetics, Protein Binding, Proto-Oncogene Proteins c-jun genetics, Proto-Oncogene Proteins c-jun metabolism, Rats, Response Elements genetics, Sequence Homology, Nucleic Acid, Transcription Initiation Site, Gene Expression Regulation, Enzymologic drug effects, Glutathione biosynthesis, NF-kappa B metabolism, Transcription Factor AP-1 metabolism, Tumor Necrosis Factor-alpha pharmacology
- Abstract
GSH synthesis occurs via two enzymatic steps catalysed by GCL [glutamate-cysteine ligase, made up of GCLC (GCL catalytic subunit), and GCLM (GCL modifier subunit)] and GSS (GSH synthetase). Co-ordinated up-regulation of GCL and GSS further enhances GSH synthetic capacity. The present study examined whether TNFalpha (tumour necrosis factor alpha) influences the expression of rat GSH synthetic enzymes. To facilitate transcriptional studies of the rat GCLM, we cloned its 1.8 kb 5'-flanking region. TNFalpha induces the expression and recombinant promoter activities of GCLC, GCLM and GSS in H4IIE cells. TNFalpha induces NF-kappaB (nuclear factor kappaB) and AP-1 (activator protein 1) nuclear-binding activities. Blocking AP-1 with dominant negative c-Jun or NF-kappaB with IkappaBSR (IkappaB super-repressor, where IkappaB stands for inhibitory kappaB) lowered basal expression and inhibited the TNFalpha-mediated increase in mRNA levels of all three genes. While all three genes have multiple AP-1-binding sites, only GCLC has a NF-kappaB-binding site. Overexpression with p50 or p65 increased c-Jun mRNA levels, c-Jun-dependent promoter activity and the promoter activity of GCLM and GSS. Blocking NF-kappaB also lowered basal c-Jun expression and blunted the TNFalpha-mediated increase in c-Jun mRNA levels. TNFalpha treatment resulted in increased c-Jun and Nrf2 (nuclear factor erythroid 2-related factor 2) nuclear binding to the antioxidant response element of the rat GCLM and if this was prevented, TNFalpha no longer induced the GCLM promoter activity. In conclusion, both c-Jun and NF-kappaB are required for basal and TNFalpha-mediated induction of GSH synthetic enzymes in H4IIE cells. While NF-kappaB may exert a direct effect on the GCLC promoter, it induces the GCLM and GSS promoters indirectly via c-Jun.
- Published
- 2005
- Full Text
- View/download PDF
23. Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1.
- Author
-
Yang H, Magilnick N, Lee C, Kalmaz D, Ou X, Chan JY, and Lu SC
- Subjects
- Animals, Binding Sites, Catalytic Domain genetics, Cells, Cultured, DNA-Binding Proteins genetics, Hydroquinones pharmacology, Liver metabolism, Mice, Mice, Knockout, NF-E2-Related Factor 1, NF-E2-Related Factor 2, NF-kappa B genetics, Nuclear Respiratory Factor 1, Nuclear Respiratory Factors, Promoter Regions, Genetic, Proto-Oncogene Proteins c-fos metabolism, RNA, Messenger analysis, RNA, Messenger metabolism, Rats, Trans-Activators genetics, Transcription Factor AP-1 genetics, Transcription, Genetic, DNA-Binding Proteins physiology, Gene Expression Regulation, Glutamate-Cysteine Ligase genetics, NF-kappa B metabolism, Trans-Activators physiology, Transcription Factor AP-1 metabolism
- Abstract
Glutamate-cysteine ligase catalytic subunit (GCLC) is regulated transcriptionally by Nrf1 and Nrf2. tert-Butylhydroquinone (TBH) induces human GCLC via Nrf2-mediated trans activation of the antioxidant-responsive element (ARE). Interestingly, TBH also induces rat GCLC, but the rat GCLC promoter lacks ARE. This study examined the role of Nrf1 and Nrf2 in the transcriptional regulation of rat GCLC. The baseline and TBH-mediated increase in GCLC mRNA levels and rat GCLC promoter activity were lower in Nrf1 and Nrf2 null (F1 and F2) fibroblasts than in wild-type cells. The basal protein and mRNA levels and nuclear binding activities of c-Jun, c-Fos, p50, and p65 were lower in F1 and F2 cells and exhibited a blunted response to TBH. Lower c-Jun and p65 expression also occurs in Nrf2 null livers. Levels of other AP-1 and NF-kappaB family members were either unaffected (i.e., JunB) or increased (i.e., Fra-1). Overexpression of Nrf1 and Nrf2 in respective cells restored the rat GCLC promoter activity and response to TBH but not if the AP-1 and NF-kappaB binding sites were mutated. Fra-1 overexpression lowered endogenous GCLC expression and rat GCLC promoter activity, while Fra-1 antisense had the opposite effects. In conclusion, Nrf1 and Nrf2 regulate rat GCLC promoter by modulating the expression of key AP-1 and NF-kappaB family members.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.